Investegate announcements from Nexstim Oyj, Nexstim Reaches Over 300 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry
Press release, Helsinki, 3 February 2022 at 3:15 PM (EET) Nexstim Reaches Over 300 Completed Treatment Sessions - Continues to Report a Remission Rate Greater than 50% of MDD